BMY 45778(152575-66-1)
- Name: BMY 45778
- Synonyms:Aceticacid, [3-(4,5-diphenyl[2,4'-bioxazol]-5'-yl)phenoxy]- (9CI); BMY 45778
- Molecular Formula:C26H18 N2 O5
- Molecular Weight:438.43
- CAS Registry Number:152575-66-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.152575-66-1 BMY 45778
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.152575-66-1 BMY 45778
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:BMY 45778
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.152575-66-1 Manufacturer supply CAS 152575-66-1 with best quality
Assay:99% Appearance:White powder Package: [Packaging]20mg, 50mg,100mg,1g,10g,100g,according to customers' requirements Storage: should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Transportation:1. Samples 1kg-10kg are shipped by international express. 2. 50kg-100kg of goods are transported by dedicated line logistics. 3. Cargo 100kg-1ton is transported by dedicated line logistics. Application:Chemical raw materials, pharmaceutical intermediates, cosmetic raw materials, etc.
Min. Order:1Kilogram
Supplier:Zhuozhou Wenxi import and Export Co., Ltd [
China (Mainland)] CAS No.152575-66-1 BMY 45778
Assay:鈮?9% by HPLC Package:inquiry Transportation:inquiry Application:BMY 45778 is a non-prostanoid prostacyclin mimetic that acts as a partial agonist of IP1 prostacyclin receptors. It inhibits platelet aggregation in vitro (IC50 = 27-35 nM).
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 619-21-6/3-Carboxybenzaldehyde
- 2317-22-8/2,6-DICYANOTOLUENE
- 72612-07-8/N-[3-(1H-Indol-3-yl)propyl]-m-nitrobenzamide
- 63038-83-5/Benz(A)anthracene-8,9-diol-10,11-epoxide, anti
- 17083-68-0/HYDROGEN TETRABROMOAURATE (III) HYDRATE (99.9%-AU)
- 68132-88-7/2-Butenedioic acid (2Z)-, polymer with 1,3-diisocyanatomethylbenzene, 1,1-((1-methylethylidene)bis(4,1-phenyleneoxy))bis(2-propanol) and 1,2-propanediol mono(2-methyl-2-propenoate)
- 14017-47-1/CERIUM PERCHLORATE
- 71539-43-0/3-Bromocinnamamide
- 3777-69-3/2-Pentylfuran
- 158999-11-2/aspartyl-tyrosyl-phosphomethionyl-aspartyl-methionyl-lysine
- 52497-68-4/THYMIDINE, [METHYL-3H]
- 1193-18-6/3-Methyl-2-cyclohexen-1-one
- 35468-36-1/alpha,alpha-Dithiobisformamidine hydrochloride
- 21868-43-9/4-(piperidin-1-yl)-6-(piperidin-1-ylmethyl)-1,3,5-triazin-2-amine
- 68411-96-1/TEA-COCOYL SARCOSINATE
- 91-04-3/2,6-Bis(hydroxymethyl)-p-cresol
- 53832-00-1/Fumaric acid, styrene, methyl methacrylate, butadiene polymer
- 33475-94-4/5-[2-(diethoxyphosphoryl)ethyl]-2,4-dimethylpyridin-3-yl acetate
- 152575-66-1/BMY 45778
- 956-02-5/4'-Chlorochalcone
- 70519-22-1/Tribetamide
- 133661-83-3/N-[(2-chlorophenyl)methylideneamino]-2,2-dimethyl-propanamide
- 18583-55-6/(2-CHLOROBENZYL)TRIPHENYLPHOSPHONIUM CHLORIDE HYDRATE
- 7377-03-9/CAPRYLOHYDROXAMIC ACID
- 22732-89-4/Riboflavin,5'-O-glucopyranosyl-
- 260-94-6/Acridine
- 12597-32-9/heptaselenepane
- 158076-62-1/2,2',3,3',4',5-HEXACHLORO-4-BIPHENYLOL
- 20103-35-9/[2-heptadecyl-4,5-dihydro-4-(hydroxymethyl)oxazol-4-yl]methyl stearate
- 68039-22-5/3,3'-[(9,10-dihydro-9,10-dioxoanthracene-1,4-diyl)diimino]bis[triethylpropylammonium] tetrachlorozincate